Shareholder Sues To Halt Vote On Merger Deal Until More Information Is Provided
NEW YORK — A shareholder of an autologous cell and gene therapy company sued the company and its board of directors in New York federal court on Nov. 11, seeking to...To view the full article, register now.
Already a subscriber? Click here to view full article